Molecular Diagnostics: Claris Life Sciences
Genetic Arms Race: Winning with Data in the Fight Against Cancer
In the high-stakes world of cancer diagnostics, precision is power. This week on unNatural Selection, we explore the fast-moving frontier of precision oncology with Caris Life Sciences, a company redefining how cancer is diagnosed and treated. Through advanced molecular profiling and AI-driven insights, Caris is helping oncologists tailor therapies to the unique genetic makeup of each tumor. We speak with President David Spetzler about the competitive landscape of molecular diagnostics, the role of innovation in staying ahead, and how data is becoming the most critical survival trait in modern medicine.
